Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNG2 | P59768 | 5/20 | 0.78 |
| ▸ | GNB1 | P62873 | 5/20 | 0.78 |
| ▸ | PHLPP2 | Q6ZVD8 | 2/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | HPGD | P15428 | 1/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.78 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.70 |
| ▸ | CHAT | P28329 | 4/20 | 0.63 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.63 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.63 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.57 |
| ▸ | P2RY12 | Q9H244 | 4/20 | 0.57 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13214229 | 0.90 | GNG2 (0.87) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| Uniblue A SCHEMBL29533348 | 0.90 | P2RY4 (0.71) | P2RY4P2RY2P2RY12P2RY6CDK2 | |
| Uniblue A SCHEMBL19921895 | 0.90 | P2RY4 (0.71) | P2RY4P2RY2P2RY12P2RY6CDK2 | |
| SCHEMBL8656578 | 0.89 | GNG2 (0.75) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL791497 | 0.89 | GNG2 (0.85) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL2781947 | 0.88 | GNG2 (1.00) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL11405626 | 0.87 | GNG2 (0.82) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL24645555 | 0.87 | GNG2 (0.59) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL20738852 | 0.86 | GNG2 (0.59) | GNG2GNB1PHLPP2CYP1A2CYP2C9 | |
| SCHEMBL373443 | 0.86 | GNG2 (0.74) | GNG2GNB1PHLPP2CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10302591-B2 | Sharply resolving labeled protein molecular weight standards | Life Technologies Corporation (US) | 2019-05-28 | — | — | US | claimed |
| US-20180031522-A1 | SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS | INVITROGEN CORPORATION | 2018-02-01 | — | — | US | claimed |
| EP-2976622-A2 | PROTEIN STANDARD | Bio-Rad Laboratories, Inc. (US) | 2016-01-27 | — | — | EP | claimed |
| US-20140311909-A1 | PROTEIN STANDARD | BIO-RAD LABORATORIES, INC (US) | 2014-10-23 | — | — | US | claimed |
| WO-2014160273-A2 | PROTEIN STANDARD | BIO-RAD LABORATORIES INC. (US) | 2014-10-02 | — | — | WO | claimed |
| WO-2011071359-A2 | COVALENT MODIFICATION OF PROTEINS FOR THE INSTANTANEOUS VISUALISATION THEREOF AND SUBSEQUENT CHARACTERISATION THROUGH MASS SPECTROMETRY | Instituto Tecnológico y de Estudios Superiores de Monterrey (MX) | 2011-06-16 | — | — | WO | claimed |
| EP-2069386-A2 | SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS | Life Technologies Corporation (US) | 2009-06-17 | — | — | EP | claimed |
| US-20090087873-A1 | SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS | INVITROGEN CORPORATION (US) | 2009-04-02 | — | — | US | claimed |
| WO-2008042495-A2 | SHARPLY RESOLVING LABELED PROTEIN MOLECULAR WEIGHT STANDARDS | Life Technologies Corporation (US) | 2008-04-10 | — | — | WO | claimed |
| EP-1865942-A2 | NOVEL INHIBITORS OF GLUTATHIONE-S-TRANSFERASE | Universität Giessen (DE) | 2007-12-19 | — | — | EP | claimed |
| WO-2006097472-A2 | NOVEL INHIBITORS OF GLUTATHIONE-S-TRANSFERASE | UNIVERSITÄT GIESSEN (DE) | 2006-09-21 | — | — | WO | claimed |
| US-20050004038-A1 | Bivalent inhibitors of Glutathione-S-Transferases | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-01-06 | — | — | US | claimed |
| WO-2004072236-A2 | METHODS AND COMPOSITIONS FOR 3-D SODIUM DODECYL SULFATE-POLYACRYLAMIDE CUBE GEL ELECTROPHORESIS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2004-08-26 | — | — | WO | claimed |
| US-5914806-A | Stable electrophoretic particles for displays | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1999-06-22 | — | — | US | claimed |
| US-5652093-A | Analogues of reporter groups as background reducers in binding assays | APROGENEX, INC. (US) | 1997-07-29 | — | — | US | claimed |
| US-5501952-A | Analogues of reporter groups as background reducers in hybridization assays | APROGENEX, INC. (US) | 1996-03-26 | — | — | US | claimed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | claimed |
| WO-2023060210-A9 | MOLECULES, AND RELATED ASSAYS, TEST KITS AND METHODS | SAPPHIRE BIOTECH, INC. (US) | 2024-04-18 | — | — | WO | disclosed |
| US-5106951-A | Antineoplastic anthracyline agents intercalated with two aromatic side chains or an oligopeptide and covalently attached to an antibody | NEORX CORPORATION (US) | 1992-04-21 | — | — | US | disclosed |
| EP-0329184-A2 | Antimers and antimeric conjugation | NEORX CORPORATION (US) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004038-A1 | Bivalent inhibitors of Glutathione-S-Transferases | GSTM1, GSTM2, GSTA2 | GNG2 342/4885GNB1 470/4885PHLPP2 2936/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.